Corticosteroids Added to Initial Intravenous Immunoglobulin Treatment for the Prevention of Coronary Artery Abnormalities in High‐Risk Patients With Kawasaki Disease

BACKGROUND: Randomized controlled trials previously provided different conclusions about the superiority of adding corticosteroids to initial intravenous immunoglobulin treatment for the prevention of coronary artery abnormalities in patients with Kawasaki disease (KD). To further assess this issue,...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Am Heart Assoc
Asıl Yazarlar: Ae, Ryusuke, Abrams, Joseph Y., Maddox, Ryan A., Schonberger, Lawrence B., Nakamura, Yosikazu, Kuwabara, Masanari, Makino, Nobuko, Matsubara, Yuri, Kosami, Koki, Sasahara, Teppei, Belay, Ermias D.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2020
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7660775/
https://ncbi.nlm.nih.gov/pubmed/32811256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.119.015308
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller